ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2015

May 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2015-05-19

Reporting Person: Bencich John (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-19	Restricted Stock Unit (RSU)	$	A	12500	Acquired	2019-06-18	Common Stock (12500)	Direct
2015-05-19	Stock Option (right to buy)	$1.86	A	25000	Acquired	2025-05-19	Common Stock (25000)	Direct

Footnotes

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.

F2: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open.

F3: The options vest in monthly installments over 48 months commencing one month from January 1, 2015